Contact this trialFirst, we need to learn more about you.
Vasodilator
INOpulse® for Pulmonary Hypertension
Recruiting1 awardPhase 3
New York, New York
This trial is testing the safety and effectiveness of a drug called inhaled nitric oxide in people at risk for pulmonary hypertension associated with pulmonary fibrosis. The trial is divided into two parts.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.